Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WXSH0102 for Vulvovaginal Candidiasis
NCT06771063Phase 2Recruiting
- Sponsor
- Cisen Pharmaceutical Co., Ltd.
- Start
- Jan 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WXSH0102 in vulvovaginal candidiasis (VVC), sponsored by Cisen Pharmaceutical Co., Ltd.. Started Jan 2025; status: recruiting.
02
Drugs
WXSH0102
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT06771063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06771063.